StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > ⚡⚡⚡ SZLS should focus on Aristotle, forget covid tests

<< Previous

Bullboard Posts

Next >>

Comment by Liked2Thinkon May 12, 2021 12:41pm

92 Views

Post# 33183354

RE:RE:⚡⚡⚡ SZLS should focus on Aristotle, forget covid tests

stop covid testing??

whoever mentioned that is an idiot.

no covid testing means this company would be worth ZERO right now.

How are they at 64 fricken cents right now. That means they havent accomplished anything since the reverse split.

Im beginning to think there is something else going on here. Cant blame this whole thing on people manipulating the price and management being clueless. Not even the combination of the two makes any sense.

As typical - crickets coming from Stage

<< Previous

Bullboard Posts

Next >>

Dollar Tree CEO Rick Dreiling steps down as discount retailer struggles